Predicting cognitive progression in parkinson's patients

• Monitoring neurodegeneration: The study, led by researchers at UPV/EHU and Biobizkaia, explores the use of retinal thickness analysis as a non-invasive method to monitor neurodegeneration in Parkinson's patients.
• Early detection of cognitive impairment: By analyzing the thickness of the innermost retinal layer using optical coherence tomography, researchers observed that retinal thinning precedes cognitive impairment in Parkinson's patients.
• Clinical implications: The findings have significant implications for identifying Parkinson's patients at risk of cognitive decline, enabling more targeted clinical treatments and facilitating advancements in clinical trials.

Parkinson's disease progression varies widely among patients, making it challenging for neurologists to predict individual outcomes accurately. Thus, making the prediction of the disease progression crucial for providing personalized care and optimizing treatment strategies for Parkinson's patients.

• Retinal Thickness Analysis: Researchers measured the thickness of the retinal layer using optical coherence tomography, a standard instrument in ophthalmological tests.
• Significant Findings: The study revealed that Parkinson's patients exhibit noticeable retinal thinning compared to individuals without the disease. This thinning correlates with cognitive decline over time.
• Temporal Relationship: Initial retinal neurodegeneration precedes cognitive and motor decline in Parkinson's patients, highlighting the potential of retinal analysis as an early predictor of disease progression.

The study results require international validation to confirm the utility of retinal thickness analysis as a predictive tool for Parkinson's progression. Improving the resolution of retinal imaging technology could enhance the accuracy and reliability of the predictive method.

The study involved collaboration with Biobizkaia and researchers from hospitals in Bizkaia and Araba. Ongoing research aims to validate the findings in another cohort of patients, highlighting the importance of continued funding for Parkinson's research.

The study offers promising insights into the use of retinal thickness analysis as a non-invasive tool for monitoring neurodegeneration in Parkinson's disease, potentially revolutionizing disease management and treatment strategies.

MEDICA-tradefair.com; Source: University of the Basque Country